retatrutide study results NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs! This data suggests retatrutide is the most

Study finds association between GLP 1 use and macular degeneration in diabetes The Pharmaceutical Journal The FDA has approved oral Wegovya daily pill option for weight loss that uses semaglutide, the same active ingredient as injectable GLP 1s. As Midi's Chief Medical Officer, Dr. Kathleen Jordan explains: if GLP 1 receptor agonists How Wegovy, Ozempic, and Mounjaro work Trulicity Lawsuit June 2026 Update King Law My GLP 1 journey originally began in September, but after a foot injury and surgery in October, I had to pause and focus on healing. I restarted in March 2026, and now 2 months later, Im back